Blood test may spot pancreatic cancer early, study hopes
NCT ID NCT06397846
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find blood-based biomarkers that can distinguish malignant pancreatic lesions from benign ones. Researchers will analyze blood samples from 100 adults with benign pancreatic conditions and compare them to existing data from patients with pancreatic cancer. The goal is to develop a clinical test that helps doctors diagnose pancreatic cancer earlier and more accurately.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PANCREATIC LESION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Nord Franche-Comté
RECRUITINGMontbéliard, France
-
University Hospital of Besancon
RECRUITINGBesançon, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.